U.S. market Open. Closes in 3 hours 34 minutes

PCRX | Pacira BioSciences, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for PCRX we got that it has average fundamentals where Valuation is considered to be undervalued, Profitability is unacceptably poor, Growth is on medium level and Health is strong.

Valuation (79%)

Company Industry
P/E Ratio (TTM) 12.22 16.83
PEG Ratio (TTM) -1.24 -22.40
P/S Ratio (TTM) 1.12 5.41
P/B Ratio (TTM) 0.88 4.28
P/FCF Ratio (TTM) 4.20 8.05
Price to 5YR AVG Earnings Ratio 15.73 28.12
Price to 5YR AVG FCF Ratio 8.94 20.99

Profitability (30%)

Company Industry
ROA (TTM) 3.86% 2.55%
ROE (TTM) 7.32% 16.58%
Net Profit Margin (TTM) 9.21% -13.15%
ROIC 5YR AVG 6.37% 9.71%

Growth (60%)

4QTR AVG 3YR AVG 5YR AVG
EPS 31.71% -319.00% -172.03%
Revenue 1.51% 17.82% 15.57%
Net Income 29.41% -296.33% -157.48%
Cash Flow 5.21% 38.91% 27.75%

Health (61%)

Company Industry
Current Ratio (TTM) 6.82 2.49
Quick Ratio (TTM) 5.70 1.85
D/E Ratio (TTM) 0.68 -0.31
Interest Coverage (TTM) 7.34 11.90
Piotroski F-Score 7 6
Altman Z-Score 1.58 4.64
LTL to 5YR AVG FCF 5.92 4.62
Shares Outstanding Growth 5YR AVG 2.48% 30.07%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙